Evidence map›Paper›PMID 38476725›Full record

ArticleCurrent developments in nutrition2024

What Technological and Economic Elements Must be Addressed to Support the Affordability, Accessibility, and Desirability of Alternative Proteins in LMIC?

Katrin Gradl, Ana Sofía Sánchez Hernández, Warren L Grayson, Tim Ja Finnigan, Hannah E Theobald, Bahman Kashi, Veronika Somoza

Abstract read
In one paragraph

Article in Current developments in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katrin GradlLeibniz-Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany.
Ana Sofía Sánchez HernándezDepartment of Biotechnology Engineering, School of Engineering, Tecnológico de Monterrey, Monterrey, N.L., Mexico.
Warren L GraysonDepartment of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Tim Ja FinniganMarlow Foods Limited, Station Road, Stokesley, United Kingdom.
Hannah E TheobaldMarlow Foods Limited, Station Road, Stokesley, United Kingdom.
Bahman KashiEconomic Evaluation and Research, Limestone Analytics, Kingston, Ontario, Canada.
Veronika SomozaLeibniz-Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Populations in low- and middle-income countries (LMIC) typically consume less than the recommended daily amount of protein. Alternative protein (AP) sources could help combat malnutrition, but this requires careful consideration of elements needed to further establish AP products in LMIC. Key considerations include technological, nutritional, safety, social, and economic challenges. This perspective analyzes these considerations in achieving dietary diversity in LMIC, using a combination of traditional and novel protein sources with high nutritional value, namely, soy, mycoprotein, and cultivated meat. Technological approaches to modulate the technofunctionality and bitter off-tastes of plant-sourced proteins facilitate processing and ensure consumer acceptance. Economic considerations for inputs, infrastructure for production, and transportation represent key elements to scale up AP. Dietary diversification is indispensable and LMIC cannot rely on plant proteins alone to provide adequate protein intake sustainably. Investments in infrastructure and innovation are urgently needed to offer diverse sources of protein in LMIC.

Indexed as

alternative proteincellular agriculturecultivated meatfermentationLMICmalnutritionmycoproteinplant-based proteinprotein technological processingtaste

Identifiers

PMID38476725
PMCPMC10926134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.